Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones-Reference-Cited by-同舟云学术

Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones

Published:2018-10 Issue:4 Volume:34 Page:674-689.e8
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

de Boer Bauke,Prick Janine,Pruis Maurien G.,Keane Peter,Imperato Maria Rosaria,Jaques Jennifer,Brouwers-Vos Annet Z.,Hogeling Shanna M.,Woolthuis Carolien M.,Nijk Marije T.,Diepstra Arjan,Wandinger Sebastian,Versele Matthias,Attar Ricardo M.,Cockerill Peter N.,Huls Gerwin,Vellenga Edo,Mulder André B.,Bonifer Constanze,Schuringa Jan Jacob

Funder

Bloodwise

European Research Council

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference79 articles.

1. Versatile humanized niche model enables study of normal and malignant human hematopoiesis;Abarrategi;J. Clin. Invest.,2017

2. Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia;Agerstam;Proc. Natl. Acad. Sci. USA,2015

3. Genetic variegation of clonal architecture and propagating cells in leukaemia;Anderson;Nature,2011

4. A leukemia-associated CD34/CD123/CD25/CD99+ immunophenotype identifies FLT3-mutated clones in acute myeloid leukemia;Angelini;Clin. Cancer Res.,2015

5. Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based niches;Antonelli;Blood,2016

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias;Blood;2024-09-12

2. Star wars against leukemia: attacking the clones;Leukemia;2024-09-02

3. Identification of leukemia stem cell subsets with distinct transcriptional, epigenetic and functional properties;Leukemia;2024-08-21

4. Automated cell type annotation and exploration of single-cell signaling dynamics using mass cytometry;iScience;2024-07

5. Immunotherapeutic targeting of surfaceome heterogeneity in AML;Cell Reports;2024-06